{"id":86160,"date":"2013-06-30T01:58:05","date_gmt":"2013-06-30T05:58:05","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/morehouse-school-of-medicine-announces-leadership-transition.php"},"modified":"2013-06-30T01:58:05","modified_gmt":"2013-06-30T05:58:05","slug":"morehouse-school-of-medicine-announces-leadership-transition","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/morehouse-school-of-medicine-announces-leadership-transition.php","title":{"rendered":"Morehouse School of Medicine Announces Leadership Transition"},"content":{"rendered":"<p><p>    ATLANTA, June 28, 2013 \/PRNewswire\/ --Today Morehouse    School of Medicine (MSM) President John E. Maupin Jr., D.D.S. announced his    planned retirement, closing a celebrated tenure and an over    30-year accomplished career in academic medicine, healthcare    administration and public health. Effective July 1, 2014,    after the end of the upcoming academic year, Dr. Maupin will be    succeeded by Valerie Montgomery Rice, M.D., a    Harvard-educated obstetrician and gynecologist, who was named    as executive vice president and dean in 2011. Dr. Montgomery    Rice will retain the position of dean when she becomes    president next year. With this announcement, Dr. Montgomery    Rice becomes the nation's first African-American woman to lead    a free-standing medical school as chief executive officer. As    dean, she will continue amongst the ranks of the 16 percent of    women serving as dean leading academic medical institutions.  <\/p>\n<p>    (Photo: <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20130628\/CL40156\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20130628\/CL40156<\/a>)  <\/p>\n<p>    In 2010, the MSM board of trustees approved a new leadership    structure that would merge the roles of dean and president upon    Dr. Maupin's retirement. This new structure is consistent with    a recent trend among the nation's medical schools-- elevating    the role of dean to chief executive officer while retaining    chief academic officer responsibilities.  <\/p>\n<p>    \"We are appreciative for the service and superior leadership    Dr. Maupin displayed during his seven-year tenure as    president,\" said Anthony Welters, chairman of MSM's board of    trustees, executive vice president of United Health Group and    member of the office of the CEO. \"Under Dr. Maupin's guidance,    the school has made significant advances, expanding academic    programs and clinical affiliations, creating innovative    partnerships, modernizing facilities, and strengthening the    infrastructure to better support research, patient care and    teaching.\"  <\/p>\n<p>    Mr. Welters went on to explain, \"The board of trustees is    confident that the carefully orchestrated succession plan helps    to maintain business continuity, provide a seamless transition,    and help to facilitate Dr. Montgomery Rice's success as the    next leader.\"  <\/p>\n<p>    \"During her tenure as dean, Dr. Montgomery Rice demonstrated    her commitment to the mission and vision of the medical    school,\" said Art R. Collins, chairman of the board of    trustees' committee on transition and founding partner of the    Collins Johnson Group. \"In our selection of Dr. Montgomery Rice    as dean, the trustees looked at a long-term strategy. We    believed the dean could ascend to leading the medical school    and her current role would provide the necessary consistency to    continue advancing the mission.\"  <\/p>\n<p>    A native of Macon, Ga., Dr. Montgomery Rice, served in numerous    leadership positions at some of the nation's most prestigious    academic and health institutions. Dr. Montgomery Rice received    an undergraduate degree in chemistry from Georgia Institute of    Technology, a medical degree from Harvard Medical School, and    completed her training in obstetrics and gynecology at Emory    University Medical School and reproductive endocrinology and    infertility at Hutzel Hospital in Detroit. A renowned    infertility expert and nationally recognized clinical    scientist, Dr. Montgomery Rice also served on numerous    professional and scientific advisory panels, national industry    boards and authored more than 50 medical research articles.  <\/p>\n<p>    \"I consider it an honor that our board is entrusting me with    the responsibility of continuing to build on the legacy of this    pre-eminent institution,\" said Dr. Montgomery Rice. \"The vision    is crystal clear. My role is to continue to further the mission    while also positioning the school to remain relevant and at the    forefront of an ever-changing medical education environment.\"  <\/p>\n<p>    During the next year, the two leaders will continue to enhance    key partnerships, advance development and philanthropic    outreach, and maintain a focus on faculty and staff engagement.  <\/p>\n<p>    Upon retirement, Dr. Maupin plans to continue to serve on    corporate and civic boards. \"Being a part of the growth and    development of Morehouse School of Medicine has been a    remarkable experience,\" said Dr. Maupin. \"Much about MSM is    highly distinctive, but what makes it so special is the    extraordinarily dedicated faculty and staff, community-focused    students, and committed trustees and alumni.\"  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Go here to read the rest:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/morehouse-school-medicine-announces-leadership-110000475.html;_ylt=AwrNUPzcyM9RimsAAQD_wgt.\" title=\"Morehouse School of Medicine Announces Leadership Transition\">Morehouse School of Medicine Announces Leadership Transition<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> ATLANTA, June 28, 2013 \/PRNewswire\/ --Today Morehouse School of Medicine (MSM) President John E. Maupin Jr., D.D.S.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/morehouse-school-of-medicine-announces-leadership-transition.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-86160","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/86160"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=86160"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/86160\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=86160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=86160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=86160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}